News

Highlights from ZeClinics and the zebrafish model

Find out about company updates and the latest discoveries in zebrafish research.

EIC-Pathfinder_EdiGenT ZECLINICS NEWS

ZeClinics has been granted €1M from the EIC-Pathfinder Challenge for the EdiGenT project to develop new technologies applied to gene therapy

ZECLINICS NEWS

EUROSTARS CARDIOMYO consortium has launched a HTS platform to identify new therapies for cardiomyopathies

zebrafish ZECLINICS NEWS

Zebrafish can repair the heart after suffering a heart attack

ZECLINICS NEWS

ZeClinics partners with the Institut de la Vision to test in zebrafish the most cutting-edge genome editing technologies

Reducing-data-heterogeneity-with-ontologies. ZECLINICS NEWS

New article publication by ZeClinics and the SEAZIT program from the National Institute of Health

new-article-publication-by-ZeClinics-and-Dompé ZECLINICS NEWS

New article publication by ZeClinics and Dompé Farmaceutici

ZECLINICS NEWS

ZeClinics reached hire 20% of its workforce in 2021

School on Genome Editing for Neuroscience Research ZECLINICS NEWS

Our scientific director will participate in teaching a school on genome editing for neuroscience research in Ghana, Africa

ZECLINICS NEWS

Filippo Del Bene, new member of ZeClinics’ Scientific Advisory Board

agreement-industrial-PhD ZECLINICS NEWS

ZeClinics and University of Messina enter into agreement to launch a joint Industrial PhD Program in Veterinary Sciences

model-human-glioma-in-zebrafish ZECLINICS NEWS

Conclusion of ZF-Glioma project

Logo_cardiomyo_project ZECLINICS NEWS

ZeClinics, Amsterdam UMC and Taros Chemicals join forces to boost drug discovery for cardiomyopathies

Gb_sciences_logo ZECLINICS NEWS

Statistical Significance in Preclinical Study of Cannabinoid formulations against Parkinson’s Disease in Zebrafish

ZECLINICS NEWS

The Use of Zebrafish Genetics in Eradicating Diseases

ZECLINICS NEWS

Magnolia bark compound discovered to potentially treat drug-resistant epilepsy

ZeClinics DZNE Agreement ZECLINICS NEWS

ZeClinics Partners with German Center for Neurodegenerative Diseases (DZNE)